黑色素瘤中的PARP1:机理性见解和对基础和临床研究的含义
Andrea Marranci1, Luisa Maresca2, Samuele Lodovichi3
1Oncohematology Unit, Fondazione Pisana per la Scienza ONLUS, San Giuliano Terme, 56017, Pisa, Italy. Electronic address: http://www.fpscience.it/.
Cancer letters
|March 2, 2025
概括
多 (ADP-ribose) 聚合酶1 (PARP1) 在黑色素瘤的发展中至关重要. PARP 抑制剂在治疗黑色素瘤方面表现有前途,但需要进一步的研究来优化它们的使用.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 遗传学 遗传学 是一个
背景情况:
- 转移性黑色素瘤的治疗已经被向疗法和免疫疗法所改变.
- PARP 抑制剂 (PARPi) 在乳腺癌和卵巢癌中表现出成功.
- 新出现的证据表明,PARP1与黑色素瘤的发病和进展有关.
研究的目的:
- 审查PARP1在黑色素瘤中的作用.
- 探索PARP抑制剂在黑色素瘤治疗中的潜力.
- 确定黑色素瘤中PARPi的挑战和未来研究方向.
主要方法:
- 在黑色素瘤中对PARP1和PARPi进行临床前和临床研究的文献综述.
- 分析PARP1表达和黑色素瘤特征之间的相关性.
- 评估PARPi作为单一治疗和联合治疗的疗效.
主要成果:
- 高PARP1表达与侵袭性黑色素瘤和患者的不良结果有关.
- PARPi显示出降低黑色素瘤细胞活力和抑制瘤生长的潜力.
- 目前关于将PARPi与现有疗法和患者选择相结合的研究是有限的.
结论:
- PARP1 在黑色素瘤中起着重要作用.
- PARPi代表了黑色素瘤的一个有前途的治疗途径.
- 进一步的基础和临床研究至关重要,以克服治疗耐药性等挑战,并为黑色素瘤患者充分利用PARPi.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K


